Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point.

Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point.
复制标题

使用 DNA 流式细胞术作为中间终点的芬维A胺治疗浅表性膀胱癌的随机试验。

DOI：
--
复制
发表时间：
2000
期刊：
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
影响因子：
--
通讯作者：
Bruzzi,P
Bruzzi,P
中科院分区：
--
文献类型：
--
作者：
Decensi,A;Torrisi,R;Bruno,S;Costantini,M;Curotto,A;Nicolo,G;Malcangi,B;Baglietto,L;Bruttini,GP;Gatteschi,B;Rondanina,G;Varaldo,M;Perloff,M;Malone,WF;Bruzzi,P

文献摘要

被引文献

相似文献